| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pacira Biosciences, Inc. (PCRX) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. PCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 399.0K | $9.38M | - | |
| Other | 218.9K | $5.15M | - | |
| Other | 167.1K | $3.93M | -10,259 | |
| CFO | 118.3K | $2.78M | - | |
| VP | 62.3K | $1.46M | -6,115 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 22, 2017 | Hastings Paul J77 | Director | Sell | 1,044 | $36.15 | $37,740.60 | -22.9% | |
| Aug 15, 2017 | Williams Kristen Marie76 | CAO And General Counsel | Sell | 3,461 | $36.75 | $127,191.75 | -14.0% | |
| Aug 15, 2017 | Stack David M67 | CEO And Chairman | Sale+OE | 28,885 | $36.37 | $1,050,547.45 | -18.1% | |
| Aug 8, 2017 | Froimson Mark72 | Director | Buy | 100 | $37.13 | $3,713.16 | New | |
| Jun 7, 2017 | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 1,119 | $44.37 | $49,650.03 | -13.7% | |
| Jun 5, 2017 | Williams Kristen Marie76 | CAO And General Counsel | Sell | 1,877 | $43.32 | $81,313.52 | -12.0% | |
| Jun 5, 2017 | Stack David M67 | CEO And Chairman | Sell | 4,311 | $43.32 | $186,756.83 | -6.7% | |
| Jun 5, 2017 | Scibetta James S | President | Sell | 1,966 | $43.32 | $85,169.09 | -7.3% | |
| Jun 5, 2017 | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 601 | $43.32 | $26,035.92 | -6.8% | |
| Jun 5, 2017 | Jones James B | SVP &Chief Medical Officer | Sell | 767 | $43.32 | $33,227.21 | -7.2% |